Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S

This letter to the editor outlines the use of stereotactic body radiotherapy for metastatic renal cell carcinoma in the U.S., identifying clinical predictors of utilization using the National Cancer Database.

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Paciotti, Marco, Schmidt, Andrew L., Ravi, Praful, McKay, Rana R., Trinh, Quoc‐Dien, Choueiri, Toni K.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2021
Teme:
Letters to the Editor
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100555/
https://ncbi.nlm.nih.gov/pubmed/33650184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13736
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items